Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Abbott Laboratories (ABT) – Abbott Laboratories Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Abbott Laboratories (ABT) trades at $101.885, down 2.0% on the day, amid bearish technical signals but strong analyst support. The stock shows robust fundamentals with a net income margin of 14.72% and ROE of 13.07%, though recent quarters saw EPS misses. Key developments include the acquisition of Exact Sciences, expanding Abbott's oncology portfolio, as reported by PRNewsWire on March 23, 2026.
Outlook remains positive with a consensus price target of $132.67, offering ~30% upside. Risks include execution of recent acquisitions and competitive pressures in healthcare. Institutional activity is mixed, with some firms reducing stakes while others increase positions, reflecting cautious optimism.
Read full analysis

Key Stats

  • Market Cap
    $178.41B
  • Sector
    Health
  • 3M Drawdown
    -20.28%
  • Enterprise Value
    $183.33B
  • Dividend Yield
    2.45%
  • Typical Hold Time
    98 days
$102.75
52W Low: $101.89
30 Mar 2026
52W High: $138.08
24 Jun 2025

Abbott Laboratories (ABT) is currently valued at a market capitalization of $178.41B, with an enterprise value of $183.33B. Over the past 52 weeks, Abbott Laboratories has traded between a low of $101.89 and a high of $138.08, highlighting its annual price range. Over the past three months, Abbott Laboratories has recorded a drawdown of -20.28%, reflecting recent price volatility. Abbott Laboratories offers a dividend yield of 2.45%, with the most recent dividend of $0.63 paid on 15 Jan 26. On average, investors hold Abbott Laboratories for approximately 98 days, indicating typical investor behavior on the platform.

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.


Technical Indicators
|
|
|
Overall Summary
Bearish (18)Neutral (1)Bullish (8)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $178.41B
  • Sector
    Health
  • 3M Drawdown
    -20.28%
  • Enterprise Value
    $183.33B
  • Dividend Yield
    2.45%
  • Typical Hold Time
    98 days
$102.75
52W Low: $101.89
30 Mar 2026
52W High: $138.08
24 Jun 2025

Abbott Laboratories (ABT) is currently valued at a market capitalization of $178.41B, with an enterprise value of $183.33B. Over the past 52 weeks, Abbott Laboratories has traded between a low of $101.89 and a high of $138.08, highlighting its annual price range. Over the past three months, Abbott Laboratories has recorded a drawdown of -20.28%, reflecting recent price volatility. Abbott Laboratories offers a dividend yield of 2.45%, with the most recent dividend of $0.63 paid on 15 Jan 26. On average, investors hold Abbott Laboratories for approximately 98 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!